NCT02338830View on ClinicalTrials.gov

Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix

PHASE4CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
Premature Labour
Interventions
DRUG

Progesterone

Women received vaginal progesterone suppositories (Cyclogest®, Actavis, Barnstaple, EX32 8NS, United Kingdom) in a dose of 400 mg daily beginning at 20-24 weeks gestational age

Trial Locations (2)

35111

Obstetrics and Gynecology Department in Mansoura University Hospital, Al Mansurah

Unknown

Private practice settings, Al Mansurah

All Listed Sponsors
lead

Mohamed Sayed Abdelhafez

OTHER

NCT02338830 - Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix | Biotech Hunter | Biotech Hunter